Argeris N. Karabelas, Director at REGENXBIO Inc. (RGNX), sold 10,000 shares at $10.11 ($101K) on 2024-10-01, disclosed to the SEC on 2024-10-02.
Scheduled sale ($101k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |
| VRX | BUY | 2016-08-12 | $99K | — | Filing → |